Heft: KVB FORUM 10/2017, Seiten 6 – 8
Artikel: Die KVB als wichtiger Player der Versorgungsforschung Autor: Dr. Martin Tauscher, Dr. Roman Gerlach, Ewan Donnachie
Literaturverzeichnis zum KVB FORUM-Artikel
„Die KVB als wichtiger Player der Versorgungsforschung“ Seiten 6 – 8
[1] Pfaff, H. & Schrappe, M. (2011). Einführung in die Versorgungsforschung. In H. Pfaff, E.
A. M Neugebauer, G. Glaeske & M. Schrappe (Hrsg.), Lehrbuch Versorgungsforschung:
Systematik – Methodik – Anwendung (S. 1–7). Stuttgart: Schattauer.
[2] McDonald, L. (2014). Florence Nightingale, statistics and the Crimean War. J. R. Stat. Soc. A, 177: 569–586. http://dx.doi.org/10.1111/rssa.12026
[3] Kassenärztliche Vereinigung Bayerns (2017). Vertragsärztliche Versorgung in Bayern und in Deutschland zukunftssicher machen!.
https://www.kvb.de/fileadmin/kvb/dokumente/Praxis/Infomaterial/Versorgung/KVB-Broschuere- vertragsaerztliche-Versorgung-Bayern-zukunftssicher.pdf
[4] Bayerische Spezialität oder Regel für Deutschland? Gutachtergremium analysiert Besonderheiten der Versorgungsstruktur in Bayern. https://www.zi.de/cms/presse/2016/18- oktober-2016/
[5] Mehring et al. (2013). Disease management programs for patients with asthma in Germany: a longitudinal population-based study.Respiratory care, vol. 58, no. 7, pp. 1170-1177.
https://doi.org/10.4187/respcare.01968
[6] Mehring et al. (2014). Disease management programs for patients with COPD in Germany:
a longitudinal evaluation of routinely collected patient records. Respiratory care, vol. 59, no. 7, pp. 1123-1132 https://doi.org/10.4187/respcare.02748
[7] Mehring et al. (2017) Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study.Diabetology & metabolic syndrome, vol. 9, pp. 37. https://doi.org/10.1186/s13098-017-0236-y
[8] Fexer et al. (2014). The effects of theophylline on hospital admissions and exacerbations in COPD patients: audit data from the Bavarian disease management program. Deutsches
Ärzteblatt international, vol. 111, no. 17, pp. 293-300. https://doi.org/10.3238/arztebl.2014.0293
[9] Beyerlein et al. (2016). Infections in early life and development of type 1 diabetes. JAMA, vol.
315, no. 17, pp. 1899-1901. https://doi.org/10.1001/jama.2016.2181
[10] Bonke et al. (2015). Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus. Diabetologia 59:286. https://doi.org/10.1007/s00125- 015-3797-z
[11] Donnachie et al. (2017). Incidence of irritable bowel syndrome and chronic fatigue following GI infection: a population-level study using routinely collected claims data. Gut. Published Online First: 10 June 2017. https://doi.org/10.1136/gutjnl-2017-313713
[12] Petersen et al. (2014). Epidemiologie der Multiplen Sklerose in Deutschland: Regionale Unterschiede und Versorgungsstruktur in Abrechnungsdaten der gesetzlichen
Krankenversicherung. Der Nervenarzt Vol. 85, Issue 8, pp. 990-998.
https://doi.org/10.1007/s00115-014-4097-4
[13] Lauseker et al (2016). Female and Elderly Chronic Myeloid Leukemia Patients Often Do Not Receive an Adequate TKI Treatment. Blood 128:3101.
http://www.bloodjournal.org/content/128/22/3101
